Fate Therapeutics Files 8-K/A Amendment
Ticker: FATE · Form: 8-K/A · Filed: Jun 17, 2025 · CIK: 1434316
| Field | Detail |
|---|---|
| Company | Fate Therapeutics Inc (FATE) |
| Form Type | 8-K/A |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, filing-update, corporate-governance
TL;DR
Fate Therapeutics filed an amendment to a shareholder vote report, check for details.
AI Summary
Fate Therapeutics, Inc. filed an 8-K/A on June 17, 2025, to amend a previous filing regarding matters submitted to a vote of security holders. The earliest event reported in this amendment was May 29, 2025. The company is incorporated in Delaware and headquartered in San Diego, California.
Why It Matters
This filing indicates an update or correction to a previous report concerning shareholder votes, which could impact investor understanding of corporate governance or strategic decisions.
Risk Assessment
Risk Level: low — This is an administrative amendment to a previous filing, not a new material event.
Key Players & Entities
- Fate Therapeutics, Inc. (company) — Registrant
- May 29, 2025 (date) — Earliest event date
- June 17, 2025 (date) — Filing date
- San Diego, CA (location) — Principal executive offices
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing is an amendment to a previous report concerning the submission of matters to a vote of security holders.
When was the earliest event reported in this filing?
The earliest event reported in this filing was May 29, 2025.
What is the filing date of this 8-K/A?
This 8-K/A was filed on June 17, 2025.
Where is Fate Therapeutics, Inc. headquartered?
Fate Therapeutics, Inc. is headquartered at 12278 Scripps Summit Drive, San Diego, CA 92131.
What is the SIC code for Fate Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Fate Therapeutics, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on June 17, 2025 regarding FATE THERAPEUTICS INC (FATE).